Articles tagged with Translational Medicine
The Center for Translational Exposomics Research (CTER) at USC aims to accelerate environmental health research and find practical solutions. CTER investigates how different exposures impact health across populations using population studies, lab experiments, and community engagement.
Dr. Philip Gold's landmark paper reveals depression's full-body impact, documenting structural brain changes and disruptions in hormone systems. His analysis highlights interconnected mechanisms underlying the disease, opening new therapeutic possibilities for innovative treatments targeting neuroendocrine dysfunction.
A collaborative study led by Dr. Julie St-Pierre at the University of Ottawa found that promoting mitochondrial elongation in cancer cells hobbles their ability to metastasize. The research team identified a common signature that could help determine which pathways lead to decreased metastasis.
JAMA launches a new series, Translational Science Reviews, providing concise summaries of important basic science discoveries transforming disease diagnosis and treatment. These reviews aim to keep clinicians informed about ongoing scientific advancements.
Researchers at Houston Methodist have identified a new strain of bacteria, Streptococcus dysgalactiae subspecies equisimilis (SDSE), linked to increasingly severe human infections. The study used integrative analysis to investigate the genome, transcriptome, and virulence of SDSE strains, shedding light on their molecular pathogenesis.
Researchers have discovered a gene called NANOG that can improve nerve regrowth and re-establish innervation in damaged muscles after traumatic nerve injuries. This discovery has significant potential to help mitigate long-term disability for people with debilitating nerve injuries.
Researchers will examine cognitive and psychomotor functions to compare effects of CBD on driving performance between men and women. The five-year study aims to provide a comprehensive understanding of the substance's influence.
A non-invasive blood test measuring circulating tumor cells can predict treatment response, disease progression, and overall survival in men with metastatic prostate cancer. Patients with more CTCs had shorter median survival lengths and a greater risk of death.
The University of Liverpool will lead a £60m national research hub to develop and manufacture new long-acting therapeutics, positioning the UK as a global leader in this field. The Hub for Advanced Long-acting Therapeutics (HALo) aims to create new proof-of-concept medicine candidates for diseases like high blood pressure and asthma.
A team of scientists has successfully mapped the entire brain of Drosophila melanogaster, a fruit fly, using electron microscopy dataset and connectome analysis. The complete map will help researchers understand how different circuits work together to control behaviors like motor control, courtship, and decision-making.
A study suggests that online insomnia treatment, SHUTi, can provide meaningful relief for caregivers struggling with sleep difficulties. The program showed promising results in improving sleep quality and reducing stress among high-intensity caregivers, those shouldering the greatest responsibilities in caring for their loved ones.
The NIH is establishing a network to integrate genomics into learning health systems, analyzing and improving the use of genomic information in patient care. The goal is to create generalizable knowledge and genomic medicine practices that can be shared with under-resourced settings, improving patient outcomes.
Researchers isolated drug-resistant strains of SARS-CoV-2 from immunocompromised individuals who received antiviral treatments. The virus variants showed resistance to Paxlovid and remdesivir, highlighting the need for combination therapy to treat COVID-19 in highly vulnerable patients.
A new study published in JAMA Health Forum found that machine learning can be more effective than traditional methods for distributing scarce treatments to patients most vulnerable during a public health crisis. The model reduces expected hospitalizations by about 27 percent compared to actual and observed care.
A new trial revealed that a lifestyle-intervention program failed to reduce cardiovascular risk factors in US South Asians, but showed promising improvements in health behaviors. The study underscores the need for culturally tailored interventions to address the unique health needs of this growing ethnic group.
Researchers have proposed a novel treatment strategy for post-acute infectious syndromes (PAIS), including Long COVID. The multimodal approach combines pharmacological interventions like metformin and low-dose naltrexone with physical therapies like extracorporeal apheresis.
Researchers discovered faulty immune processes responsible for lingering lung issues after COVID-19, which can be disrupted by existing drugs. The study also identified molecules responsible for the issue and potential therapeutic options for patients with ongoing lung damage.
Researchers at CNIC discover clonal hematopoiesis as a new cause of atherosclerosis, while identifying the ancient medication colchicine as a potential treatment. Clonal hematopoiesis is linked to an increased risk of cardiovascular disease, with no influence on the progression of mutated blood cells.
Researchers at the University of Virginia School of Engineering and Applied Science have designed a drug-carrying molecule that can slip past the lung's natural defenses. The nanocarrier, called PEG-BB, is shaped like a bottlebrush and mimics the properties of mucus, allowing it to move quickly through the airway.
Researchers have identified lower levels of certain amino acids in the blood plasma of patients with unexplainable chronic itch, offering a potential breakthrough in treating this debilitating condition. These findings may pave the way for new targeted therapies.
The Ontario Institute for Cancer Research is providing nearly $6 million to eight research teams across Ontario, supporting studies that aim to diagnose and treat cancers more effectively. The Clinical Translational Pathway program will advance new discoveries and bring them to the healthcare system.
Research from the University of Virginia School of Medicine reveals that nearly a quarter of children with recurrent wheezing have undetected lung infections that do not respond to commonly prescribed steroids. The study suggests that antiviral medications such as azithromycin may be a more effective treatment for these cases.
Researchers at St. Jude Children's Research Hospital have discovered DNA methylation patterns that help identify the root cause of developmental and epileptic encephalopathies, a condition affecting 1 in 590 children. The findings provide a new tool for diagnosing children with DEE and could lead to more effective treatments.
ICU patients with contractile weakness of the diaphragm due to mechanical ventilation develop a state of hibernation, where myosin protein is trapped in an energy-saving state. This compromises diaphragm strength and independent breathing, leading to difficulties in weaning from the ventilator. Researchers have found a potential lead f...
Researchers at UVA discovered an unknown cause of long COVID inside lung tissues, promoting chronic inflammation that drives lasting respiratory symptoms. They found that immune cells can go haywire and promote tissue scarring, leading to conditions like interstitial lung disease.
Researchers designed a molecule, MTX-531, that impairs signaling drivers of cancer therapy resistance. In mouse models, MTX-531 led to tumor regressions in multiple head and neck cancers, showing a favorable toxicity profile.
A team of scientists at the University of Sydney has repurposed a commonly used blood thinner, heparin, as an inexpensive antidote for cobra venom. The discovery could drastically reduce the impact of snakebites worldwide, particularly in low- and middle-income countries where cobra species account for most snakebite incidents.
Researchers at Weill Cornell Medicine used machine learning to define three subtypes of Parkinson’s disease, each with distinct driver genes and molecular mechanisms. These subtypes may suggest customized treatment strategies for patients, potentially targeting specific drugs such as metformin to slow down progression.
Researchers identified a viable path to developing a novel therapy that would make opioids more effective and safer as a treatment for chronic pain. The study found that selective Hsp90 inhibitors amplified the pain-relieving effects of morphine, reducing tolerance and side effects.
Scientists have identified a critical genetic mechanism driving cardiac fibrosis and found a novel target for its reversal. The discovery sheds light on the role of transforming growth factor-beta (TGFβ) and ATP-citrate lyase (ACLY) in promoting excessive tissue scarring, providing hope for new heart failure treatments.
Scientists identify PI3K gamma as a key player in recruiting damaging myeloid cells to infected tissues, and show that inhibiting this enzyme with eganelisib can prevent excessive inflammation. The study provides a new approach to preventing irreversible organ damage in infectious diseases like COVID-19.
Researchers at Weill Cornell Medicine have identified cellular and molecular markers that can predict when pancreatic cancer will spread to the liver or other organs. The study found that patients with early-stage pancreatic cancer who showed signs of immune exhaustion were more likely to develop liver metastases.
A Phase 1 clinical trial is underway to evaluate the safety and efficacy of an investigational monoclonal antibody targeting enterovirus D68 (EV-D68), a virus associated with severe respiratory and neurological diseases. The trial will assess the antibody's potency, duration of action, and optimal dose in healthy volunteers.
Researchers at the Lewis Katz School of Medicine will investigate how injured heart cells communicate with other cells throughout the body using microvesicles known as exosomes. The study aims to understand how specific molecules, such as microRNAs, facilitate communication pathways between cells in the heart and vasculature.
The Collaborative Ethics model, developed by Jeantine Lunshof and Julia Rijssenbeek, aims to address ethical implications of emerging technologies from fundamental discoveries. By integrating philosophical and ethical reassessment into research processes, the model facilitates decision points for researchers and ethicists.
A new study found that market-ready steers can maintain high-quality beef even when fed lower-cost maintenance diets. The research showed no significant differences in meat quality between two diet groups, suggesting flexibility in feeding strategies.
Researchers found that adding an anti-inflammatory drug to immune checkpoint inhibitor therapy resulted in a high response rate of 67% among patients with stage 4 non-small cell lung cancer. The study suggests that reducing chronic inflammation may improve the effectiveness of immunotherapy.
Researchers analyzed three tumor markers for associations with radiographic response and clinical outcomes in NSCLC patients. The study found that CEA, CA-125, and CA-19-9 were associated with progression and radiographic responses in NSCLC.
Researchers used single-cell sequencing technology to study immune responses in healthy adult volunteers exposed to SARS-CoV-2. They discovered unique immune responses associated with resisting sustained viral infection and disease, including activation of specialized mucosal immune cells and a reduction in inflammatory white blood cells.
Researchers created an artificial lymph node using hyaluronic acid, which connects with T-cells via a cell surface receptor. The noden acted as a learning hub, stimulating T-cells to recognize and kill cancer cells in mice with melanoma and colon cancers.
Researchers developed a novel immunotherapy approach using ultrasound to deliver chemotherapy and antibodies to the brain, boosting immune system recognition of glioblastoma cells. The treatment showed promise in improving responses to PD-1 blockade in patients with advanced brain tumors.
Researchers at the University of North Carolina's Gillings School of Global Public Health have developed a new oral antiviral drug, obeldesivir (GS-5245), which has shown efficacy in treating COVID-19 in mice. The study suggests that obeldesivir could be a promising tool in future pandemic preparedness.
In a proof-of-concept study, USC researchers used functional ultrasound imaging to collect high-resolution brain imaging data through a transparent skull implant in a patient. The results suggest that this approach could open new avenues for patient monitoring and clinical research.
A breakthrough in trauma care has nearly quadrupled the 'golden hour' for treating large animals with internal bleeding during emergency ground and air transport. Researchers used a closed-loop, autonomous intervention system to resuscitate pigs with traumatic injuries, extending their survival time by several hours.
A study by Trinity College Dublin researchers has linked rare mast cell types to treatment response in chronic spontaneous urticaria (CSU), a common skin condition characterized by recurring hives. The findings suggest that these cells may help predict who will respond well to anti-IgE therapies.
Scientists have developed a functional model of thoracic aortic aneurysm using human cells in laboratory rats, offering new avenues for drug development and effective screening. The model successfully mimics dilation of the human aorta and has potential applications for treating this potentially fatal condition.
Researchers found that iron is a regulator of energy usage by immune cells in the lungs, which can help treat asthma and other allergic diseases. Blocking or limiting iron uptake may reduce asthma severity.
A late University of Virginia School of Medicine scientist's research on the SAS1B protein could lead to new cancer treatments for multiple cancers. The discovery has the potential to selectively target cancer cells while sparing healthy tissue.
A massive study identifies new biomarkers for renal cell carcinoma subtypes, improving diagnosis and treatment. The researchers' integrative analysis of proteogenomic datasets reveals molecular features shared by clear cell and non-clear cell RCC tumors, as well as unique features to various subtypes.
Researchers at the University of Missouri have developed a soft, self-charging material that can track vital signs like blood pressure and heart activity wirelessly. This innovation has significant implications for early disease detection and timely interventions in chronic conditions.
A study by Mount Sinai researchers has identified several pathophysiological mechanisms underlying perianal fistulae in Crohn’s disease. The findings highlight key transcription factor binding events and epigenetic phenomena that contribute to the higher rates of complications in African American patients. The research provides avenues...
A comprehensive atlas of ageing human muscle reveals genetic and cellular processes behind muscle deterioration, including new cell populations that may explain age-related differences. The study also identifies compensatory mechanisms to counteract ageing, offering avenues for future therapies.
Researchers have identified three distinct immunological endophenotypes of multiple sclerosis, defined by specific blood immune signatures. These findings could lead to more effective and tailored treatment strategies for patients with the disease.
Researchers at Weill Cornell Medicine have developed a novel method to create grafts that accurately replicate the human ear's anatomy and biomechanical properties. The new technique uses 3D printing and tissue engineering to produce cartilage-containing structures that mimic the ear's shape, flexibility, and elasticity.
A second-generation melanoma vaccine has shown improved survival rates for male patients compared to female patients, particularly those who are younger and have earlier-stage cancer. The vaccine targets helper T cells to recognize melanoma proteins, leading to boosted patient survival and reduced cancer reoccurrences.
Researchers present findings on immunotherapy approaches, a potential biomarker for neuroendocrine carcinomas, and improved treatments for pancreatic cancer and melanoma. A UCLA team identified UCHL1 as a molecular indicator and therapeutic target for aggressive neuroendocrine cancers.
Young adults in Korea with ideal cardiovascular health had significantly lower risks of developing heart disease, stroke, and kidney disease. The study highlights the importance of achieving and maintaining ideal heart health during young adulthood to prevent these diseases.
A free, weekly home delivery program of fresh fruits and vegetables improved participants' nutrition levels, physical activity levels, and cardiovascular disease risk factors. The 16-week program resulted in significant improvements in food insecurity, diet quality, and indicators of cardiovascular health.
Researchers propose combining osimertinib with gefitinib to increase progression-free survival rates in EGFR-mutant lung cancer patients. A comprehensive PC approach could dramatically boost PFS for 80% of patients, eliminating harm and improving treatment outcomes.
Researchers found that initial vaccinations against the ancestral SARS-CoV-2 strain shape immune responses to newer variants BA.5 and XBB, with higher B cell repertoire leading to more effective cross-reactive immunity. This 'immunological imprinting' effect could impact future vaccine designs.